Credit Suisse’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-19,049
| Closed | -$2.04M | – | 3287 |
|
|
2023
Q1 | $2.04M | Buy |
19,049
+2,089
| +12% | +$224K | ﹤0.01% | 1838 |
|
|
2022
Q4 | $1.87M | Buy |
16,960
+7,893
| +87% | +$868K | ﹤0.01% | 1912 |
|
|
2022
Q3 | $535K | Buy |
9,067
+142
| +2% | +$8.38K | ﹤0.01% | 2726 |
|
|
2022
Q2 | $251K | Sell |
8,925
-2,110
| -19% | -$59.3K | ﹤0.01% | 3223 |
|
|
2022
Q1 | $417K | Sell |
11,035
-1,104
| -9% | -$41.7K | ﹤0.01% | 3058 |
|
|
2021
Q4 | $480K | Buy |
+12,139
| New | +$480K | ﹤0.01% | 3048 |
|